Tectonic Therapeutic, Inc.

NASDAQ: TECX · Healthcare · Biotechnology

PublicHQ Watertown, MA · MiddlesexCIK 0001681087Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 63DQ —GM —SS 58

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, Altman-Z · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$74.2M

Employees

as of 2026-08-11

Market cap

$617.2M

as of 2026-08-11

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$74.2M-$74.2M2025

Operating income-$84.0M-$84.0M2025

Total assets$261.0M$261.0M2025

Liabilities$9.7M$9.7M2025

Equity$251.3M$251.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Tectonic Therapeutic, Inc.’s financial profile?

Tectonic Therapeutic, Inc. earned -$74.2M in FY2025 net income.

Peers · Healthcare

BridgeBio Oncology Therapeutics Inc.——Cybin Inc. Common Stock——Jade Biosciences, Inc.——Adlai Nortye Ltd.——GMR Solutions Inc.——Odyssey Therapeutics, Inc.——

Neighbors

Middlesex →

GE Vernova Inc.$38.1B63C Thermo Fisher Scientific Inc.$44.6B86A Analog Devices, Inc.$11.0B87A The TJX Companies, Inc.$60.4B85A Boston Scientific Corporation$20.1B88A Symbotic Inc.$2.2B49D

Key facts

CEOAlise S. Reicin

SectorHealthcare

IndustryBiotechnology

HeadquartersWatertown, MA

ExchangeNASDAQ: TECX

Employees60

IPO date2018-06-21

Latest filings

10-Q2026-08-06 8-K2026-08-06 8-K2026-06-10 10-Q2026-05-07 8-K2026-05-07 DEF 14A2026-04-24 8-K2026-04-23 10-K2026-02-26

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.